Read more

November 28, 2020
2 min read
Save

Top news in COVID-19 and the heart: Fauci at AHA, telehealth and more

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Healio and Cardiology Today have compiled a list of the top-read news in COVID-19 and CV health.

Readers were most interested in a talk by Anthony S. Fauci, MD, on COVID-19 and the heart, telehealth amid the pandemic, hydroxychloroquine and arrhythmia risk and more.

Breaking News
Source: Adobe Stock

Fauci: Underlying CVD drives risk for COVID-19 severity, death

COVID-19 can cause severe CV complications, manifested by arrythmias, myocardial injury, thromboembolic phenomenon and cardiomyopathies, Fauci said during a presentation at the American Heart Association Scientific Sessions. Read more

COVID-19 CVD registry highlights racial/ethnic disparities, risk in obesity

CVD complications in patients with COVID-19 are less common than were believed, but COVID-19 complications disproportionately affect patients with obesity and Black and Hispanic individuals, according to new registry data. Read more

Telehealth shift during COVID-19 pandemic shows capacity to safely deliver cardiology care

As clinicians around the world rapidly transitioned from in-person to telehealth visits during the COVID-19 pandemic, it required managing many changes at once. Read more

Business of cardiology ‘severely disrupted’ by COVID-19 pandemic

The COVID-19 pandemic has disrupted our current way of life, comparable in magnitude perhaps to transformations that followed the Great Plague of the Middle Ages and the Spanish influenza pandemic of 1918-1920. Read more

Viewpoint: COVID-19 resembles endothelial disease, anti-inflammatory therapies may help

COVID-19 resembles an endothelial disease and treating it with anti-inflammatory agents, similarly to other endothelial diseases, may be appropriate, according to a viewpoint published in the European Heart Journal. Read more

Short-term COVID-19 treatment with hydroxychloroquine may not confer arrhythmia risk

Hydroxychloroquine may be safe for the short-term treatment of patients with COVID-19 who were chosen for therapy after undergoing risk assessment, researchers found. Read more

COVID-19 may increase risk for HFpEF

There may be a link between COVID-19 and HF with preserved ejection fraction, as infection from SARS-CoV-2 may cause, unmask or exacerbate HFpEF, according to a viewpoint published in JAMA. Read more

In COVID-19 hospitalizations, survival after cardiac arrest very low

In a single-center experience, no patients hospitalized with COVID-19 who developed cardiac arrest survived to discharge after receiving CPR, researchers found. Read more

Racial, ethnic health disparities, already prevalent, growing worse due to COVID-19

Health equity and acknowledgment of disparities among Black and Hispanic individuals is of paramount concern, especially amid the COVID-19 pandemic, according to a presentation at the virtual Cardiometabolic Health Congress. Read more

CPR success, survival to discharge in out-of-hospital cardiac arrest dropped amid COVID-19

Rates of return of spontaneous circulation and survival to discharge for out-of-hospital cardiac arrest declined in the U.S. early during the COVID-19 pandemic compared with the previous year, researchers reported. Read more